Brief: Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
20/10/2026 23:04
BRIEF-Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Oct 20 (Reuters) - Atrium Therapeutics Inc RNA.O:
ATRIUM THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Source text: ID:nPn8QtBqQa
Further company coverage: RNA.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Atrium Therapeutics
See all newsBrief: Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Yakira Capital Management Calls On Atrium Therapeutics To Launch Strategic Review
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Atrium Therapeutics rallies after $50 mln equity raise